Astrazeneca Share Discussion Threads

[bunz3] 05/8/2020 17:30

hoping a good day here tomorrow if news on ncyt share board is correct

[bunz3] 05/8/2020 16:18

hoping for good finish here after reading ncyt share board ,

[buywell3] 05/8/2020 01:49

buywell finds this article somewhat of a concern

It explains why SARS-CoV-2 has become so easily transmissible but in doing so opens up a whole can of possibly nasty worms

29 Mar 2020

SARS-CoV-2 Prion-Like Domains in Spike Proteins Enables Higher Affinity to ACE2



buywell notes:

This disease, Covid-19 is killing off vast numbers of elderly people in Care Homes.
Also many people over the age of 75 , where the chances of them having some form of dementia also is a lot higher than people under the age of 60 ( see posts for stats).


The cost of keeping care homes going (increasing daily) and the numbers needing care (increasing daily) plus those elderly people with Alzheimer's ( number one in the dementia category ) and Parkinson's disease (number two) are also growing daily , both numbers and costs.

buywell has posted about these costs escalating and gobbling up big percentages of Health budgets worldwide on this AZN thread.

The authors do not say that these strange shaped spiky β-CoV prion like protein domains are prion proteins.

But IF this disease does return or recur to reinfect the person again after testing clear ( are tests reliable ??) , it still remains a possibility that Covid-19 just might turn out to be lethal like other prion diseases such as Alzheimer's .

But it takes a couple of years or so to do the job.

dyor

[ayl30] 04/8/2020 06:59

https://www.thetimes.co.uk/article/oxford-coronavirus-vaccine-may-be-financial-shot-in-the-arm-for-huawei-jf792n9bd?shareToken=272f769191f01d407d3b36314017d4dd

[beckers2008] 03/8/2020 10:23

3rd August 2020 08:20 | AstraZeneca PLC

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9500p (from 9000p).

[ayl30] 03/8/2020 06:16

https://www.nytimes.com/2020/08/01/world/asia/coronavirus-vaccine-india.html

[ayl30] 03/8/2020 06:04

In case you cannot openhttps://www.thetimes.co.uk/article/the-profit-motive-puts-big-pharma-on-the-spot-as-it-hunts-for-a-vaccine-9s8vvb39q?shareToken=a8b7fb0b13af353e9f94177f0e55db4d

[dudishes] 02/8/2020 02:52

Phase III underway, what phase are Moderna on? No big issue, as been here since 2009. I do think we are in a different league, yes?

[gregb] 30/7/2020 09:40

Lol. Modern haven't made any margin on Covid. They haven't even got any drug to market yet!

[chillpill] 30/7/2020 09:23

Moderna are making 10x the margin that AZN are on COVID. Discuss. UK being too soft and should be using profits to kick start UK economy in new era of protectionism?

[ygor705] 30/7/2020 09:01

Not the easiest of reports to follow but once you finally get to the 2020/2019 comparative earnings there are a very good set of numbers being reported here. No increase in the dividend also suggests that a lot of money is being ploughed back into the business at the moment. Don't seem much not to like here.

[hotfinance14] 30/7/2020 08:27

Great results. What an incredible company.

[steeplejack] 30/7/2020 07:43

This is a core holding.The cash flow generation is terrific.

[marcela9] 30/7/2020 07:42

agreed - encouraging

[thamestrader] 30/7/2020 07:28

results make better reading than GSK's yesterday

[montyhedge] 29/7/2020 18:08

I reckon GSK/Sanofi will win the Coronavirus vaccine race.

[thamestrader] 29/7/2020 07:52

Buywell hath indeed thpoken, and thamethtrader (whoth short attention thpan ith not quite ath shorth as amt'th) hath had a look at the link and hath found it to be interethting. Of corth thamethtrader ith too thtupid to know if it'th a seriouth thing, but to his naive little brain it thertainly lookth pothitive.

[ayl30] 29/7/2020 07:23

Good rns today

[amt] 29/7/2020 06:21

amt writes Buywell hath spoken but amt says it's a long post so he can't be bothered to waste his time reading it.

[kamitora] 27/7/2020 20:09

Oxford vaccine enters final phase of COVID-19 trials. Here's what happens now.